Related references
Note: Only part of the references are listed.All-Cause Mortality in Patients With Diabetes Under Treatment With Dapagliflozin: A Population-Based, Open-Cohort Study in The Health Improvement Network Database
Konstantinos A. Toulis et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2017)
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
Bruce Neal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Sulphonylurea compared to DPP-4 inhibitors in combination with metformin carries increased risk of severe hypoglycemia, cardiovascular events, and all-cause mortality
Jan W. Eriksson et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2016)
Evaluation of Bone Mineral Density and Bone Biomarkers in Patients With Type 2 Diabetes Treated With Canagliflozin
John P. Bilezikian et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
Effects of Canagliflozin on Fracture Risk in Patients With Type 2 Diabetes Mellitus
Nelson B. Watts et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
Possible adverse effects of SGLT2 inhibitors on bone
Simeon I. Taylor et al.
LANCET DIABETES & ENDOCRINOLOGY (2015)
Dapagliflozin maintains glycaemic control while reducing weight and body fat mass over 2 years in patients with type 2 diabetes mellitus inadequately controlled on metformin
J. Bolinder et al.
DIABETES OBESITY & METABOLISM (2014)
Long-term study of patients with type 2 diabetes and moderate renal impairment shows that dapagliflozin reduces weight and blood pressure but does not improve glycemic control
Donald E. Kohan et al.
KIDNEY INTERNATIONAL (2014)
Impact of diabetes on inpatient mortality and length of stay for elderly patients presenting with fracture of the proximal femur
K. Nirantharakumar et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2013)
The Risk of Hip Fracture After Initiating Antihypertensive Drugs in the Elderly
Debra A. Butt et al.
ARCHIVES OF INTERNAL MEDICINE (2012)
Dapagliflozin has no effect on markers of bone formation and resorption or bone mineral density in patients with inadequately controlled type 2 diabetes mellitus on metformin
O. Ljunggren et al.
DIABETES OBESITY & METABOLISM (2012)
Long-term use of thiazolidinediones and fractures in type 2 diabetes: a meta-analysis
Yoon K. Loke et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2009)
Type 1 and type 2 diabetes and incident hip fractures in postmenopausal women
KK Nicodemus et al.
DIABETES CARE (2001)
Share Paper
